Search

Dirk P Dittmer

from Chapel Hill, NC
Age ~58

Dirk Dittmer Phones & Addresses

  • 72005 Wilkinson, Chapel Hill, NC 27514 (919) 260-1695
  • Nichols Hills, OK
  • Menlo Park, CA

Work

Company: Unc lineberger comprehensive cancer center Jan 2015 Position: Unc vironomics core

Education

Degree: Doctorates, Doctor of Philosophy School / High School: Princeton University 1990 to 1994 Specialities: Molecular Biology, Philosophy

Skills

Qpcr • Molecular Biology • Cancer Research • Pcr • Cell Biology • Sequencing • Dna • Molecular Cloning • Biochemistry • Western Blotting • Biomarkers • Flow Cytometry • Cancer • Protein Expression • Viruses • Vaccines • Drug Discovery • Clinical Trials • Infectious Diseases • Tissue Culture • Cell Culture • Assay Development • High Throughput Screening • Virology • Life Sciences • Polymerase Chain Reaction • Clinical Research • Real Time Pcr • Nextgen Sequencing • West Nile Virus • Primates • Real Time Polymerase Chain Reaction • Transgenic Mice • Bioinformatics

Languages

English • German

Interests

Children • Data Analysis Using R • Environment • Education • Science and Technology • Viruses • Photography (Micro and Macro) • Animal Welfare • Cancer • Health

Industries

Higher Education

Resumes

Resumes

Dirk Dittmer Photo 1

Unc Vironomics Core

View page
Location:
Chapel Hill, NC
Industry:
Higher Education
Work:
Unc Lineberger Comprehensive Cancer Center
Unc Vironomics Core

U Oklahoma Hsc Jan 1999 - Dec 2004
Assistant Professor

University of North Carolina at Chapel Hill Jan 1999 - Dec 2004
Professor

Ucsf Jan 1997 - Jan 1999
Postdoc

Stanford University Jan 1994 - Jan 1996
Postdoc
Education:
Princeton University 1990 - 1994
Doctorates, Doctor of Philosophy, Molecular Biology, Philosophy
Freie Universität Berlin 1984 - 1989
Skills:
Qpcr
Molecular Biology
Cancer Research
Pcr
Cell Biology
Sequencing
Dna
Molecular Cloning
Biochemistry
Western Blotting
Biomarkers
Flow Cytometry
Cancer
Protein Expression
Viruses
Vaccines
Drug Discovery
Clinical Trials
Infectious Diseases
Tissue Culture
Cell Culture
Assay Development
High Throughput Screening
Virology
Life Sciences
Polymerase Chain Reaction
Clinical Research
Real Time Pcr
Nextgen Sequencing
West Nile Virus
Primates
Real Time Polymerase Chain Reaction
Transgenic Mice
Bioinformatics
Interests:
Children
Data Analysis Using R
Environment
Education
Science and Technology
Viruses
Photography (Micro and Macro)
Animal Welfare
Cancer
Health
Languages:
English
German

Publications

Us Patents

Rna Virus Vaccines And Methods

View page
US Patent:
20070292453, Dec 20, 2007
Filed:
Dec 14, 2006
Appl. No.:
11/639023
Inventors:
Robert Floyd - Oklahoma City OK, US
Dirk Dittmer - Chapel Hill NC, US
International Classification:
A61K 39/00
A61P 43/00
US Classification:
424204100
Abstract:
The invention is a vaccine, and method of vaccination, against RNA viruses, including RNA viruses in the family Flaviviridae, which includes for example West Nile Virus, Yellow fever virus, Dengue fever virus, Hepatitis C virus, Pestiviruses, Bovine viral diarrhea virus, and Classical Swine fever virus, wherein the vaccine comprises the RNA virus or immunogenic portions thereof, which have been treated with and rendered non-pathogenic by a phenothiazine dye and visible light, the phenothiazine dyes, including, but not limited to, Methylene Blue (MB), Methylene Green, 1-methyl MB, 1,9-dimethyl MB, Azure A, Azure B, Azure C, thionine, and toluidine blue, or by squalene. The invention includes novel strains of WNV for use in producing a vaccine, and novel primers and their use in recognizing and amplifying all of or portions of the WNV genome for diagnosing WNV infections, for quality control of the vaccine, or for identifying the presence of WNV in blood or blood products.

Rna Virus Vaccines And Methods

View page
US Patent:
20110045024, Feb 24, 2011
Filed:
Aug 2, 2010
Appl. No.:
12/848753
Inventors:
Dirk P. Dittmer - Chapel Hill NC, US
Robert A. Floyd - Oklahoma City OK, US
International Classification:
A61K 39/12
US Classification:
4242181, 4242041
Abstract:
The invention is a vaccine, and method of vaccination, against RNA viruses, including RNA viruses in the family Flaviviridae, which includes for example West Nile Virus, Yellow fever virus, Dengue fever virus, Hepatitis C virus, Pestiviruses, Bovine viral diarrhea virus, and Classical Swine fever virus, wherein the vaccine comprises the RNA virus or immunogenic portions thereof, which have been treated with and rendered non-pathogenic by a phenothiazine dye and visible light. The invention includes novel strains of WNV for use in producing a vaccine.
Dirk P Dittmer from Chapel Hill, NC, age ~58 Get Report